Skip to content

The effect of standard or higher protein feeding on indicator amino acid oxidation in ICU patients

The effect of standard or higher protein feeding on indicator amino acid oxidation in ICU patients - IAAO-IC

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON53266
Enrollment
8
Registered
2023-06-29
Start date
2023-11-08
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eiwitbehoefte Protein requirement

Interventions

Subjects will undergo two test days in randomized order during which they receive either enteral feeding according to a standard protein dose (1.3 g/kg/d) or a higher protein dose (2.0 g/kg/d). Cont

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • >= 18 years old • Unplanned admission to the ICU • Mechanically ventilated • Start of enteral nutrition within 2 days of intubation • >= 3 days on enteral nutrition • Expected remaining ICU stay on mechanical ventilation of >= 2 days

Exclusion criteria

Exclusion criteria: • Contra-indication for enteral nutrition at the discretion of the treating physician • Feeding intolerance during incremental feeding protocol • Moribund or withholding of treatment • On extracorporeal membrane oxygenation (ECMO) • Presence of chest drains, pneumothorax, tracheoesophageal fistula or subcutaneous emphysema • Kidney failure AND a *no dialysis*-code on admission • Hepatic encephalopathy (West Haven criteria 3-4) • BMI < 18 kg/m2

Design outcomes

Primary

MeasureTime frame
The primary endpoint is indicator amino acid oxidation after enteral feeding with a standard or higher protein content, determined using the Indicator Amino Acid Oxidation (IAAO) method by measuring 13CO2 enrichment in expired breath and enrichment of L-[1-13C]-phenylalanine in plasma and urine.

Secondary

MeasureTime frame
To determine carbon dioxide production, 13CO2 production, plasma and urine L-[1-13C]-phenylalanine enrichments, plasma phenylalanine concentration, and fecal output and protein content in ICU patients when applying the IAAO technique.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 14, 2026